Sarcoglycanopathy: Clinical and histochemical characteristics in 66 patients

Neurology India

Volumn 58, Issue 5, 2010, Pages 691-696

  Nalini, A ^a   Gayathri, N ^a   Thaha, Fazil ^a   Das, Sarala ^b   Shylashree, S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b Kalinga Hospital Ltd   (India)

Author keywords

Immunohistochemistry; sarcoglycan; sarcoglycanopathy; southern India

Indexed keywords

CREATINE KINASE; SARCOGLYCAN;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CREATINE KINASE BLOOD LEVEL; ELECTROMYOGRAPHY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; ONSET AGE; RETROSPECTIVE STUDY; SARCOGLYCANOPATHY;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; DYSTROGLYCANS; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; SARCOGLYCANOPATHIES; SARCOGLYCANS; YOUNG ADULT;

EID: 78149370394     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.72164     Document Type: Article

References (46)

1. Gowers WR. Psuedo-hypertrophic muscular paralysis. Lancet 1879;ii:37-9,73-5,113-6.
2. Campbell K. Adhalin gene mutations and autosomal recessive limb-girdle muscular dystrophy. Ann Neurol 1995;38:353-4.
3. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. Dystrophin associated proteins in muscular dystrophy. Hum Mol Genet 1995;4:1711-6.
4. Nigro V, de Sá Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996;14:195-8.
5. Jung D, Duclos F, Apostol B, Straub V, Lee JC, Allamand V, et al. Caracterization of delta-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J Biol Chem 1996;271:32321-9.
6. Matsumura K, Tome FM, Collin H, Azibi K, Chaouch M, Kaplan JC, et al. Deficiency of the 50K-dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 1992;359:320-2.
7. Ben Hamida M, Fardeau M, Attia N. Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia. Muscle Nerve 1983;6:469-80.
8. Fardeau M, Matsumura K, Tome FM, Collin H, Leturcq F, Kaplan JC, et al. Deficiency of the 50kDa dystrophin associated glycoprotein (adhalin) in severe autosomal recessive muscular dystrophies in children native in European countries. C R Acad Sci III 1993;316:799-804.
9. Romero NB, Tome FM, Leturcq F, el Kerch FE, Azibi K, Bachner L, et al. Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiency. C R Acad Sci Paris III 1994;317:70-6.
10. Morandi L, Barresi R, Di Blasi C, Jung D, Sunada Y, ConfalonieriV, et al. Clinical heterogeneity of adhalin deficiency. Ann Neurol 1996;39:196-202.
11. Passos-Bueno MR, Oliveira JR, Bakker E, Anderson RD, Marie SK, Vainzof M, et al. Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50-DAG analysis. Hum Mol Genet 1993;11:1945-7.
12. Bueno MR, Moreira ES, Vainzof M, Chamberlain J, Marie SK, Pereira L, et al. A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy. Hum Mol Genet 1995;4:1163-7.
13. Sewry CA, Sansome A, Matsumura K, Campbell KP, Dubowitz V. Deficiency of the 50kDa dystrophin-associated glycoprotein and abnormal expression of utrophin in two South Asian cousins with variable expression of severe childhood autosomal recessive muscular dystrophy. Neuromuscul Discord 1994;4:121-9.
14. Kawai H, Akaike M, Endo T, Adachi K, Inui T, Mitsui T, et al. Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency. J Clin Invest 1995;96:1202-7.
15. Hayashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: Immunocytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin. Neurology 1995;45:551-4.
16. McNally EM, Duggan D, Gorospe JR, Bonnemann CG, Famin M, Pegoraro E, et al. Mutations that disrupt the carboxyl terminus of a-sarcoglycan cause muscular dystrophy. Hum Mol Genet 1996;5:1841-7.
17. Yoshida M, Noguchi S, Wakabayashi E, Piluso G, Belsito A, Nigro V, et al. Biochemical identification of δ-sarcoglycan. FEBS Lett 1997;403:143-8.
18. Yoshida M, Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 1990;108:748-52.
19. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, et al. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995;11:266-73.
20. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, et al. Beta-sarcoglycan: Characterization and role in the limb-girdle dystrophy linked to 4q12. Nat Genet 1995;11:257-65.
21. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995;270:819-22.
22. Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierre M, Anderson RD, et al. Missense mutations in adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994;78:625-33.
23. Eymard B, Romero NB, Leturcq F, Piccolo F, Carrie A, Jeanpierre M, et al. Primary adhalinopathy (sarcoglycanopathy): Clinical, pathologic and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 1997;48:1227-34.
24. Fanin M, Duggan DJ, Mostacciuolo ML, Martinello F, Freda MP, Sorarú G, et al. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet 1997;34:973-7.
25. Sharma MC, Mannan R, Singh NG, Gulati S, Kalra V, Sarkar C. Sarcoglycanopathies: An enigmatic form of muscular dystrophy- A report of 7 cases. Neurol India 2004;52:446-9.
26. Khadilkar SV, Singh RK, Katrak SM. Sarcoglycanopathies. A report of 25 cases. Neurol India 2002;50:27-32.
27. Meena AK, Sreenivas C, Sundaram C, Rajasekhar R, Sita JS, Borgohain R, et al. Sarcoglycanopathies: A clinico-pathological study. Neurol India 2007;55:117-21.
28. Van der Kooi AJ, Ginjaar HB, Busch HF, Wokke JH, Barth PG, de Visser M. Limb girdle muscular dystrophy. A pathological and immunohistochemical re-evaluation. Muscle Nerve 1998;21:584-90.
29. Urtasun M, Saenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;121:1735-47.
30. Duggan DJ, Hoffman EP. Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex. Neuromuscul Disord 1996;6:475-82.
31. Jeanpierre M, Carrie A, Piccolo F, Leturcq F, Azibi K, De Toma C, et al. From adhalinopathies to alpha-sarcoglycanopathies: An overview. Neuromuscul Disord 1996;6:463-5.
32. Barréis R, Confalonieri V, Lanfossi M, Di Blasi C, Torchiana E, Mantegazza R, et al. Concomitant deficiency of β-and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients. Immunohistochemical analysis and clinical aspects. Acta Neuropathol 1997;94:28-35.
33. Mizuno Y, Noguchi S, Yamamoto H, Yoshida M, Suzuki A, Hagiwara Y, et al. Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle. Biochem Biophys Res Commun 1994;203:979-83.
34. Higuchi I, Kawai H, Umaki Y, Kawajiri M, Adachi K, Fukunaga H, et al. Different manners of sarcoglycan expression in genetically proven α-sarcoglycan deficiency and γ-sarcoglycan deficiency. Acta Neuropathol 1998;96:202-6.
35. Ben Othmane K, Ben Hamida M, Pericak-Vance MA, Ben Hamida C, Blel S, Carter SC, et al. Linkage of Tunisian autosomal recessive Duchenne-like muscular dystrophy to the pericentromeric region of chromosome 13q. Nat Genet 1992;2:315-7.
36. Stubjen JP. Limb girdle muscular dystrophy. Description of a phenotype. Muscle Nerve 1994;17:1449-55.
37. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RC, Marie SK, et al. The sarcoglycan complex in the six autosomal recessive limbgirdle muscular dystrophies. Hum Mol Genet 1996;5:1963-9.
38. Emery AE. Population frequencies of inherited neuromuscular diseases: A world survey. Neuromuscul Disord 1991;1:19-29.
39. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. The seven autosomal recessive limb-girdle muscular dystrophies (LGMD) in the Brazilian population from LGMD2A to LGMD2G. Am J Med Genet 1999;82:392-8.
40. Kapoor S, Tatke M, Aggarwal S, Gupta A. Beta-Sarcoglycanopathy. Indian J Pediatr 2005;72:71-4.
41. Beckmann JS, Brown RH, Muntoni F, Urtizberea A, Bonnemann C, Bushby KM. 66th/67th ENMC sponsored international workshop. The limb-girdle muscular dystrophies, 26-28 March 1999, Naarden, The Netherlands. Neuromuscul Disord 1999;9:436-45.
42. Melacini P, Fanin M, Duggan DJ, Freda MP, Berardinelli A, Danieli GA, et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 1999;22:473-9.
43. Dincer P, Leturcq F, Richard I, Piccolo F, Yalnizoglu D, de Toma C, et al. A biochemical, genetic and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997;42:222-9.
44. Nalini A, Gayathri N. Dysferlinopathy: A clinical and histopathological study of 28 patients from Southern India. Neurol India 2008;56:379-85.
45. Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, et al. Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol 2006;65:995-1003.
46. Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M. From dystroglycanopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy. Muscle Nerve 1998;21:421-38.